Search Results - P. Guerreschi
- Showing 1 - 6 results of 6
-
1
Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study) by Nicolas Bertrand, P. Guerreschi, Nicole Basset‐Séguin, Philippe Saïag, A. Dupuy, S. Dalac‐Rat, Véronique Dziwniel, C. Depoortere, Alain Duhamel, Laurent Mortier
Published 2021Artigo -
2
Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors by Paola Corazao-Rozas, P. Guerreschi, Fanny André, Pierre-Elliott Gabert, Steve Lancel, Salim Dekiouk, Delphine Fontaine, Meryem Tardivel, Ariel Savina, Bruno Quesnel, Laurent Mortier, Philippe Marchetti, Jérôme Kluza
Published 2016Artigo -
3
Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor by Paola Corazao-Rozas, P. Guerreschi, Manel Jendoubi, Fanny André, Aurélie Jonneaux, C. Scalbert, Guillaume Garçon, Myriam Malet‐Martino, Stéphane Balayssac, Stéphane Rocchi, Ariel Savina, Pierre Formstecher, Laurent Mortier, Jérôme Kluza, Philippe Marchetti
Published 2013Artigo -
4
Blepharocheilodontic syndrome is a CDH1 pathway–related disorder due to mutations in CDH1 and CTNND1 by Jamal Ghoumid, Morgane Stichelbout, Anne‐Sophie Jourdain, Frédéric Frénois, S. Lejeune-Dumoulin, Marie‐Pierre Alex‐Cordier, Marine Lebrun, P. Guerreschi, V. Duquennoy-Martinot, Matthieu Vinchon, Joël Ferri, Matthieu Jung, Serge Vicaire, Clémence Vanlerberghe, Fabienne Escande, Florence Petit, Sylvie Manouvrier‐Hanu
Published 2017Artigo -
5
Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors by Raeeka Khamari, Anne Trinh, Pierre Elliott Gabert, Paola Corazao-Rozas, Samuel Riveros-Cruz, Stéphane Balayssac, Myriam Malet‐Martino, Salim Dekiouk, Marie Joncquel-Chevalier Curt, Patrice Maboudou, Guillaume Garçon, Laura Ravasi, P. Guerreschi, Laurent Mortier, Bruno Quesnel, Philippe Marchetti, Jérôme Kluza
Published 2018Artigo -
6
Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants by Jérôme Kluza, Paola Corazao-Rozas, Yasmine Touil, Manel Jendoubi, Cyril Maire, P. Guerreschi, Aurélie Jonneaux, Caroline Ballot, Stéphane Balayssac, Samuel Valable, Aurélien Corroyer‐Dulmont, Myriam Bernaudin, Myriam Malet‐Martino, Elisabeth Martin de Lassalle, Patrice Maboudou, Pierre Formstecher, Renata Polakowska, Laurent Mortier, Philippe Marchetti
Published 2012Artigo
Search Tools:
Related Subjects
Biology
Biochemistry
Cancer research
Mitochondrion
Internal medicine
Medicine
Melanoma
Oxidative stress
Cancer
Cell biology
Chemistry
Enzyme
Gene
MAPK/ERK pathway
Metastatic melanoma
Oxidative phosphorylation
Phosphorylation
Vemurafenib
Apoptosis
Basal cell
Basal cell carcinoma
Breast cancer
CDH1
Cadherin
Cancer cell
Cell
Clinical trial
Context (archaeology)
Ectodermal dysplasia
Endoplasmic reticulum